RA Capital Management »

Cidara Therapeutics shares owned by RA Capital Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.6M 703k 10.75

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)
Biogen SH (BIIB)
Dyne Therapeutics SH (DYN)
Rxsight SH (RXST)
Bicara Therapeutics SH
Climb Bio SH (ELYM)
Ars Pharmaceuticals SH (SPRY)

View all positions for RA Capital Management

Top funds holding Cidara Therapeutics

RA Capital Management
BVF
Monashee Investment Management
Vanguard Group
Checkpoint Capital
Renaissance Technologies
Alethea Capital Management
5AM Venture Management
Geode Capital Management
BlackRock
BlackRock
Northern Trust
Schonfeld Strategic Advisors
State Street Corporation
Russell Investments

View all funds holding Cidara Therapeutics